Clinical Trial Details
EORTC-06083-LG
Back to Clinical Trials Database
Clofarabine added to prephase and consolidation therapy in acute lymphoblastic leukemia in adults. A prospective randomized trial.
Trial Status | Closed to Patient Entry |
---|---|
Dates |
Date of activation: 19-Dec-2011 Date Step1 close: 10-Nov-2016 |
Data management at EORTC | No |
Design |
Phase 2-3 Randomized open label |
Targeted Sample size | EORTC Groups: 15 - All Groups: 340 |
Treatment |
Drug Mercaptopurine, Tioguanine, Clofarabine, Cytarabine, Daunorubicin, Doxorubicin, Etoposide, Leucovorin, Methotrexate, Prednisolone, Prednisone, Vinblastine, Vincristine, Vindesine, Dexamethasone |
Study Staff |
Jean-Pierre Marie (Study Coordinator) , APHP Sorbonne Univ- Hopital Saint Antoine, PARIS Claire Gandilhon (Clinical Operations Assistant) , EORTC Headquarters, Brussels Tim Verbiest (Data Manager) , EORTC Headquarters, Brussels Laurens Vinckier (Pharmacovigilance Manager) , EORTC Headquarters, Brussels Gaetan de Schaetzen (Senior Clinical Operations Manager) , EORTC Headquarters, Brussels |
Type of cancer | Acute Lymphocytic Leukemia |
Participating groups |
EORTC Leukemia Group Hemato-Oncologie Volwassenen Nederland |
Recruiting centers | APHP Sorbonne Univ- Hopital Saint Antoine (PARIS, France) |
Protocol summary | http://clinicaltrials.gov/study/ |
NCT number | |
EudraCT | 2008-005798-36 |
Financial Support | EORTC Group |